MBIO logo

MBIOMustang Bio Inc

$0.7397
$0.0583
(7.31%)
Today
Closed $0.7397
$0.0185
(2.50%)
After Hours
Updated: 07:50 PM EDT
Reported EarningsAug 12
Mkt Cap$6.05M
Vol46,087.00
News
all
press releases
News Placeholder
MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy
Mustang Bio surges 180% after its brain cancer therapy, MB-101, earns FDA Orphan Drug status for two rare brain tumor types.
Zacks
News Placeholder
Mustang Bio Ignites Bullish Retail Buzz As FDA Grants Orphan Status To Brain Cancer Drug
The company is advancing a novel combination of its CAR-T drug MB-101 and oncolytic virus MB-108, with both treatments currently enrolling patients in Phase 1 trials.
Stocktwits
News Placeholder
Carmell, Mustang Bio, Revelation Biosciences Dominate Retail Biotech Talk As 2025 Kicks Off
From acquisition news and FDA designations to fresh optimism for struggling stocks, these biotechs piqued Stocktwits users the most on the first trading day of 2025.
Stocktwits
<
...
1
>

Advertisement|Remove ads.